Latest Insider Transactions at Boston Scientific Corp (BSX)
This section provides a real-time view of insider transactions for Boston Scientific Corp (BSX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of BOSTON SCIENTIFIC CORP to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of BOSTON SCIENTIFIC CORP's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 20
2023
|
Joseph Michael Fitzgerald EVP & Group Pres, Cardiology |
SELL
Open market or private sale
|
Direct |
15,867
-7.42%
|
$872,685
$55.0 P/Share
|
|
Sep 15
2023
|
Wendy Carruthers EVP, Human Resources |
SELL
Open market or private sale
|
Direct |
11,671
-16.98%
|
$618,563
$53.95 P/Share
|
|
Sep 15
2023
|
Wendy Carruthers EVP, Human Resources |
BUY
Exercise of conversion of derivative security
|
Direct |
6,408
+4.56%
|
$89,712
$14.7 P/Share
|
|
Sep 12
2023
|
Michael F Mahoney Chairman, President & CEO |
SELL
Open market or private sale
|
Direct |
113,355
-7.03%
|
$6,007,815
$53.91 P/Share
|
|
Sep 12
2023
|
Michael F Mahoney Chairman, President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
113,355
+3.46%
|
$1,586,970
$14.7 P/Share
|
|
Aug 31
2023
|
Michael F Mahoney Chairman, President & CEO |
BUY
Bona fide gift
|
Indirect |
1,095
+0.62%
|
-
|
|
Aug 30
2023
|
Michael F Mahoney Chairman, President & CEO |
BUY
Bona fide gift
|
Indirect |
141,450
+44.68%
|
-
|
|
Aug 30
2023
|
Michael F Mahoney Chairman, President & CEO |
SELL
Bona fide gift
|
Direct |
318,218
-17.51%
|
-
|
|
Aug 29
2023
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
SELL
Open market or private sale
|
Direct |
4,657
-7.14%
|
$251,478
$54.5 P/Share
|
|
Aug 28
2023
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
SELL
Open market or private sale
|
Direct |
13,971
-17.64%
|
$740,463
$53.14 P/Share
|
|
Aug 25
2023
|
Vance R Brown SVP, GC and Corp. Secretary |
SELL
Open market or private sale
|
Direct |
15,750
-35.53%
|
$787,500
$50.52 P/Share
|
|
Aug 21
2023
|
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC |
SELL
Open market or private sale
|
Direct |
6,600
-36.67%
|
$330,000
$50.4 P/Share
|
|
Aug 18
2023
|
Charles J Dockendorff Director |
SELL
Open market or private sale
|
Direct |
17,079
-81.23%
|
$853,950
$50.74 P/Share
|
|
Aug 15
2023
|
Wendy Carruthers EVP, Human Resources |
SELL
Open market or private sale
|
Direct |
11,671
-15.77%
|
$595,221
$51.3 P/Share
|
|
Aug 15
2023
|
Wendy Carruthers EVP, Human Resources |
BUY
Exercise of conversion of derivative security
|
Direct |
6,408
+4.24%
|
$89,712
$14.7 P/Share
|
|
Aug 02
2023
|
Jonathan Monson SVP, Global Controller and CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
487
-1.34%
|
$24,350
$50.62 P/Share
|
|
Aug 02
2023
|
Jonathan Monson SVP, Global Controller and CAO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,090
+2.91%
|
-
|
|
Jul 17
2023
|
Wendy Carruthers EVP, Human Resources |
SELL
Open market or private sale
|
Direct |
11,671
-14.73%
|
$606,892
$52.85 P/Share
|
|
Jul 17
2023
|
Wendy Carruthers EVP, Human Resources |
BUY
Exercise of conversion of derivative security
|
Direct |
6,408
+3.96%
|
$89,712
$14.7 P/Share
|
|
Jul 03
2023
|
Jessica L Mega Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,253
+50.0%
|
-
|
|
Jul 03
2023
|
Susan E Morano Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,082
+33.98%
|
-
|
|
Jul 01
2023
|
Vance R Brown SVP, GC and Corp. Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
1,359
-2.97%
|
$73,386
$54.09 P/Share
|
|
Jul 01
2023
|
Vance R Brown SVP, GC and Corp. Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
4,036
+8.12%
|
-
|
|
Jul 01
2023
|
Jonathan Monson SVP, Global Controller and CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
326
-0.92%
|
$17,604
$54.09 P/Share
|
|
Jul 01
2023
|
Jonathan Monson SVP, Global Controller and CAO |
BUY
Exercise of conversion of derivative security
|
Direct |
729
+2.01%
|
-
|
|
Jun 21
2023
|
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC |
SELL
Open market or private sale
|
Direct |
6,697
-27.73%
|
$354,941
$53.8 P/Share
|
|
Jun 15
2023
|
Wendy Carruthers EVP, Human Resources |
SELL
Open market or private sale
|
Direct |
11,671
-13.81%
|
$618,563
$53.24 P/Share
|
|
Jun 15
2023
|
Wendy Carruthers EVP, Human Resources |
BUY
Exercise of conversion of derivative security
|
Direct |
6,408
+3.72%
|
$89,712
$14.7 P/Share
|
|
May 16
2023
|
Joseph Michael Fitzgerald EVP & Group Pres, Cardiology |
SELL
Open market or private sale
|
Direct |
63,339
-22.85%
|
$3,356,967
$53.6 P/Share
|
|
May 16
2023
|
Joseph Michael Fitzgerald EVP & Group Pres, Cardiology |
BUY
Exercise of conversion of derivative security
|
Direct |
56,921
+17.04%
|
$739,973
$13.08 P/Share
|
|
May 15
2023
|
Wendy Carruthers EVP, Human Resources |
SELL
Open market or private sale
|
Direct |
11,671
-13.0%
|
$618,563
$53.49 P/Share
|
|
May 15
2023
|
Wendy Carruthers EVP, Human Resources |
BUY
Exercise of conversion of derivative security
|
Direct |
6,408
+3.51%
|
$89,712
$14.7 P/Share
|
|
May 04
2023
|
Nelda J Connors Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,946
+30.9%
|
-
|
|
May 04
2023
|
Charles J Dockendorff Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,946
+15.8%
|
-
|
|
May 04
2023
|
David J Roux Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,946
+5.09%
|
-
|
|
May 04
2023
|
Ellen M Zane Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,946
+7.96%
|
-
|
|
May 04
2023
|
John E Sununu Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,946
+7.35%
|
-
|
|
May 04
2023
|
David S Wichmann Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,946
+9.73%
|
-
|
|
May 02
2023
|
Eric Francis Yves Thepaut EVP & Pres, Eur, Mid-East, Afr |
SELL
Open market or private sale
|
Direct |
83,401
-87.18%
|
$4,336,852
$52.49 P/Share
|
|
May 02
2023
|
Eric Francis Yves Thepaut EVP & Pres, Eur, Mid-East, Afr |
BUY
Exercise of conversion of derivative security
|
Direct |
30,688
+24.29%
|
$368,256
$12.89 P/Share
|
|
May 02
2023
|
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC |
SELL
Payment of exercise price or tax liability
|
Direct |
932
-3.72%
|
$48,464
$52.9 P/Share
|
|
May 02
2023
|
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC |
BUY
Exercise of conversion of derivative security
|
Direct |
2,101
+7.73%
|
-
|
|
May 02
2023
|
John Bradley Sorenson EVP, Global Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
1,917
-4.97%
|
$99,684
$52.9 P/Share
|
|
May 02
2023
|
John Bradley Sorenson EVP, Global Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
4,203
+9.82%
|
-
|
|
Apr 17
2023
|
Wendy Carruthers EVP, Human Resources |
SELL
Open market or private sale
|
Direct |
11,671
-12.28%
|
$595,221
$51.96 P/Share
|
|
Apr 17
2023
|
Wendy Carruthers EVP, Human Resources |
BUY
Exercise of conversion of derivative security
|
Direct |
6,408
+3.31%
|
$89,712
$14.7 P/Share
|
|
Apr 05
2023
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
SELL
Open market or private sale
|
Direct |
4,903
-5.87%
|
$245,150
$50.4 P/Share
|
|
Apr 03
2023
|
David S Wichmann Director |
BUY
Grant, award, or other acquisition
|
Direct |
41
+0.13%
|
-
|
|
Mar 31
2023
|
Jonathan Monson SVP, Global Controller and CAO |
SELL
Open market or private sale
|
Direct |
5,000
-12.54%
|
$250,000
$50.0 P/Share
|
|
Mar 31
2023
|
Jonathan Monson SVP, Global Controller and CAO |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+11.14%
|
$60,000
$12.89 P/Share
|